Literature DB >> 7020347

Magnesium deficiency. Etiology and clinical spectrum.

E B Flink.   

Abstract

Magnesium deficiency may complicate many diseases. The causes include the following: inadequate intake during starvation or increased requirement during early childhood, pregnancy, or lactation; excessive losses of magnesium as a result of malabsorption from the gastrointestinal tract or from the kidneys during use of diuretics; and to a combination of the two, as in alcoholism. Most often the etiological factors have been operative for a month or more. Acute hypomagnesemia can occur without previous Mg deficiency after epinephrine, cold stress and stress of serious injury or extensive surgery. The clinical manifestations depend on the age of the patient and may begin insidiously or with dramatic suddenness, or there may be no overt symptoms or signs. The manifestations can be divided into the following categories: totally non-specific symptoms and signs ascribable to the primary disease; neuromuscular hyperactivity including tremor, myoclonic jerks, convulsions, Chvostek sign, Trousseau sign (rarely), spontaneous carpopedal spasm (rarely), ataxia, nystagmus and dysphagia; psychiatric disturbances from apathy and coma to some of all facets of delirium; cardiac arrhythmias including ventricular fibrillation and sudden death; hypocalcemia which is responsive only to Mg therapy; and hypokalemia which is not easily nor completely corrected without Mg therapy. The diversity of etiologies and the multiplicity of manifestations result in confusion and controversy. The documentation of normal renal function is absolutely necessary for maximum doses. The order of magnitude of dose is 1.0 meq Mg/kg on day 1, and 0.3 to 0.5 mEq/kg per day for 3 to 5 days. In emergencies such as convulsions or ventricular arrhythmias, a bolus injection of 1.0 gm (8.1 meq) of MgSO4 is indicated. Therapy of Mg deficiency in the presence of renal insufficiency requires smaller doses and frequent monitoring. Complete repletion occurs slowly.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7020347     DOI: 10.1111/j.0954-6820.1981.tb02648.x

Source DB:  PubMed          Journal:  Acta Med Scand Suppl        ISSN: 0365-463X


  25 in total

1.  Iron accumulation in tissues of magnesium-deficient rats with dietary iron overload.

Authors:  M Kimura; K Yokoi
Journal:  Biol Trace Elem Res       Date:  1996-02       Impact factor: 3.738

2.  Proton pump inhibitor-induced hypomagnesemia: A new challenge.

Authors:  Matilda Florentin; Moses S Elisaf
Journal:  World J Nephrol       Date:  2012-12-06

3.  Trousseau sign in hypocalcemia.

Authors:  Habib U Rehman; Shane Wunder
Journal:  CMAJ       Date:  2011-02-28       Impact factor: 8.262

Review 4.  Hypocalcaemia and chronic alcohol intoxication: transient hypoparathyroidism secondary to magnesium deficiency.

Authors:  C Hermans; C Lefebvre; J P Devogelaer; M Lambert
Journal:  Clin Rheumatol       Date:  1996-03       Impact factor: 2.980

5.  Does parenteral magnesium sulfate have an antiemetic effect during chemotherapy with cis-platinum?

Authors:  P E Ballmer; W H Reinhart
Journal:  Cancer Chemother Pharmacol       Date:  1989       Impact factor: 3.333

6.  Proton-pump inhibitor use is associated with low serum magnesium concentrations.

Authors:  John Danziger; Jeffrey H William; Daniel J Scott; Joon Lee; Li-wei Lehman; Roger G Mark; Michael D Howell; Leo A Celi; Kenneth J Mukamal
Journal:  Kidney Int       Date:  2013-01-16       Impact factor: 10.612

Review 7.  The elderly patient. A special case for diuretic therapy.

Authors:  D E Hyams
Journal:  Drugs       Date:  1986       Impact factor: 9.546

8.  Ventricular extrasystoles during thiazide treatment: substudy of MRC mild hypertension trial.

Authors: 
Journal:  Br Med J (Clin Res Ed)       Date:  1983-10-29

9.  Low blood mononuclear cell magnesium content and hypocalcemia in normomagnesemic patients.

Authors:  E Ryzen; T A Nelson; R K Rude
Journal:  West J Med       Date:  1987-11

10.  Magnesium deficiency as a cause of acute intractable seizures.

Authors:  D Nuytten; J Van Hees; A Meulemans; H Carton
Journal:  J Neurol       Date:  1991-08       Impact factor: 4.849

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.